Site icon pharmaceutical daily

Oregon Bioscience Association Appoints Eight New Board Members

PORTLAND, Ore.–(BUSINESS WIRE)–#biojobsOregon Bioscience Association, the trade association for the bioscience industry in Oregon, today announced the appointments of Peter Barr-Gillespie, Ph.D., Heather Ellis, Ritchard Englehardt, M.A., Tina Guldberg, Lisa Hale, Sean McClain, Todd Predmore, and Sandra Shotwell, Ph.D., to its board.

“With backgrounds in research, strategic partnering, government affairs, construction and industry leadership, our newest members join us with a broad range of experience,” said Liisa Bozinovic, Executive Director of Oregon Bio. “As our latest economic impact report shows, Oregon’s growing bioscience industry footprint reached $10.7 billion, creating 47,238 jobs for $1.5 billion in wages across 820 business establishments in 2017. As the region continues to build its leadership position in scientific research and innovation, it is important to diversify the expertise of our current board and engage new leaders in our mission.

The eight members join Oregon Bio’s board with a wide range of skills and knowledge:

View Oregon Bio’s full Board of Directors here.

About Oregon Bio

The Oregon Bioscience Association seeks to create opportunity through advocacy, cultivation, education and group purchasing discounts for its members and the sector. Oregon Bio promotes the growth and quality of the bioscience industry in Oregon and continually seeks ways to support sustainability, acceleration and growth in the life science, bioscience, biotechnology and device manufacturing industries. Oregon Bio, a nonprofit membership association, affiliates with BIO (Biotechnology Innovation Organization), and AdvaMed (Advanced Medical Technology Association).

The region’s most current bioscience economic impact study showed in 2017 Oregon’s growing bio footprint reached $10.7 billion, creating 47,238 jobs for $1.5 billion in wages across 820 business establishments. Between 2002-2017, total bioscience employment in Oregon jumped 72 percent among the five industry subsectors. Health-related R&D at Oregon hospitals and universities generated $669 million in economic activity in 2017. In 2015, federal research funding to Oregon institutions totaled more than $363 million. Venture capital investments in Oregon’s bioscience-related companies have increased in recent years and between 2014 to 2017, totaled $76.5 million.

BIO’s “Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life 2018” report showed Oregon attracted 1,274 bioscience and related patents. BIO also found Oregon is emerging in several bioscience areas, with job growth in four of the five major subsectors from 2007 to 2016. Oregon’s share of NIH funding is growing.

For more information about Oregon Bioscience Association, please visit www.oregonbio.org. Connect with us on LinkedIn and Twitter.

Contacts

Liisa Bozinovic, Executive Director, (503) 548-4432

Dianne Danowski Smith, Publix Northwest, (503) 201-7019

Exit mobile version